|
[1]
|
Jia LF, Quan MN, Fu Y, Zhao T, Li Y, Wei CB, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol 2020;19(1):81 − 92. https://doi.org/10.1016/S1474-4422(19)30290-XCrossRef
|
|
[2]
|
Guan H, Yue L, Yap PT, Xiao SF, Bozoki A, Liu MX. Attention-guided autoencoder for automated progression prediction of subjective cognitive decline with structural MRI. IEEE J Biomed Health Inform 2023;27(6):2980 − 9. https://doi.org/10.1109/JBHI.2023.3257081CrossRef
|
|
[3]
|
Jia LF, Du YF, Chu L, Zhang ZJ, Li FY, Lyu DY, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 2020;5(12):e661 − 71. https://doi.org/10.1016/S2468-2667(20)30185-7CrossRef
|
|
[4]
|
Liu D, Li L, An LN, Cheng GR, Chen C, Zou MJ, et al. Urban-rural disparities in mild cognitive impairment and its functional subtypes among community-dwelling older residents in central China. Gen Psychiatr 2021;34(5):e100564. https://doi.org/10.1136/gpsych-2021-100564CrossRef
|
|
[5]
|
Wang XQ, Huang WJ, Su L, Xing Y, Jessen F, Sun Y, et al. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease. Mol Neurodegener 2020;15(1):55. https://doi.org/10.1186/s13024-020-00395-3CrossRef
|
|
[6]
|
Chen HH, Sun FJ, Yeh TL, Liu HE, Huang HL, Kuo BIT, et al. The diagnostic accuracy of the Ascertain Dementia 8 questionnaire for detecting cognitive impairment in primary care in the community, clinics and hospitals: a systematic review and meta-analysis. Fam Pract 2018;35(3):239 − 46. https://doi.org/10.1093/fampra/cmx098CrossRef
|
|
[7]
|
Su R, Jia SR, Zhang NN, Wang YY, Li H, Zhang DL, et al. The effects of long-term high-altitude exposure on cognition: a meta-analysis. Neurosci Biobehav Rev 2024;161:105682. https://doi.org/10.1016/j.neubiorev.2024.105682CrossRef
|
|
[8]
|
Burtscher J, Mallet RT, Burtscher M, Millet GP. Hypoxia and brain aging: neurodegeneration or neuroprotection? Ageing Res Rev 2021;68:101343. http://dx.doi.org/10.1016/j.arr.2021.101343. |
|
[9]
|
Nemy M, Dyrba M, Brosseron F, Buerger K, Dechent P, Dobisch L, et al. Cholinergic white matter pathways along the Alzheimer’s disease continuum. Brain 2023;146(5):2075 − 88. https://doi.org/10.1093/brain/awac385CrossRef
|
|
[10]
|
Kulshreshtha A, Parker ES, Fowler NR, Summanwar D, Ben Miled Z, Owora AH, et al. Prevalence of unrecognized cognitive impairment in federally qualified health centers. JAMA Netw Open 2024;7(10):e2440411. https://doi.org/10.1001/jamanetworkopen.2024.40411CrossRef
|